Does providing routine liver volume assessment add value when performing CT surveillance in cirrhotic patients?
- PMID: 31359098
- PMCID: PMC6744349
- DOI: 10.1007/s00261-019-02145-6
Does providing routine liver volume assessment add value when performing CT surveillance in cirrhotic patients?
Abstract
Background: The measurement of liver volume (LV) is considered to be an effective prognosticator for postoperative liver failure in patients undergoing hepatectomy. It is unclear whether LV can be used to predict mortality in cirrhotic patients.
Methods: We enrolled 584 consecutive cirrhotic patients who underwent computerized topography (CT) of the abdomen for hepatocellular carcinoma surveillance and 50 age, gender, race, and BMI-matched controls without liver disease. Total LV (TLV), functional LV (FLV), and segmental liver volume (in cm3) were measured from CT imaging. Cirrhotic subjects were followed until death, liver transplantation, or study closure date of July 31, 2016. The survival data were assessed with log-rank statistics and independent predictors of survival were performed using Cox hazards model.
Results: Cirrhotic subjects had significantly lower TLV, FLV, and segmental (all except for segments 1, 6, 7) volume when compared to controls. Subjects presenting with hepatic encephalopathy had significantly lower TLV and FLV than those without HE (p = 0.002). During the median follow-up of 1145 days, 112 (19%) subjects were transplanted and 131 (23%) died. TLV and FLV for those who survived were significantly higher than those who were transplanted or dead (TLV:1740 vs. 1529 vs. 1486, FLV 1691 vs. 1487 vs. 1444, p < 0.0001). In the Cox regression model, age, MELD score, TLV, or FLV were independent predictors of mortality.
Conclusion: Baseline liver volume is an independent predictor of mortality in subjects with cirrhosis. Therefore, it may be useful to provide these data while performing routine surveillance CT scan as an important added value. Further studies are needed to validate these findings and to better understand their clinical utility.
Keywords: Diagnostic imaging; Liver; Portal hypertension.
Conflict of interest statement
Figures


Similar articles
-
Liver volumetry in cirrhotic patients with or without hepatocellular carcinoma: Its correlation with Child-Pugh, model for end-stage liver diseases and indocyanine green dye test.Indian J Gastroenterol. 2024 Aug;43(4):760-767. doi: 10.1007/s12664-023-01490-1. Epub 2024 Feb 13. Indian J Gastroenterol. 2024. PMID: 38349461
-
The critical value of remnant liver volume-to-body weight ratio to estimate posthepatectomy liver failure in cirrhotic patients.J Surg Res. 2014 May 15;188(2):489-95. doi: 10.1016/j.jss.2014.01.023. Epub 2014 Jan 24. J Surg Res. 2014. PMID: 24569034
-
Volumetric assessment and clinical predictors of cirrhosis in patients undergoing hepatectomy for hepatocellular carcinoma with presumed normal liver function.Hepatol Int. 2021 Oct;15(5):1258-1267. doi: 10.1007/s12072-021-10246-y. Epub 2021 Aug 23. Hepatol Int. 2021. PMID: 34426889
-
HIGHER VALUES IN LIVER ELASTOGRAPHY AND MELD SCORE ARE MORTALITY PREDICTORS ON LIVER TRANSPLANT WAITING LIST.Arq Bras Cir Dig. 2018 Jun 21;31(1):e1360. doi: 10.1590/0102-672020180001e1360. Arq Bras Cir Dig. 2018. PMID: 29947694 Free PMC article.
-
Hepatocellular Carcinoma in the Cirrhotic Liver: Evaluation Using Computed Tomography and Magnetic Resonance Imaging.Exp Clin Transplant. 2017 Mar;15(Suppl 2):36-44. doi: 10.6002/ect.TOND16.L10. Exp Clin Transplant. 2017. PMID: 28301997 Review.
Cited by
-
The impact of hepatic and splenic volumetric assessment in imaging for chronic liver disease: a narrative review.Insights Imaging. 2024 Jun 18;15(1):146. doi: 10.1186/s13244-024-01727-3. Insights Imaging. 2024. PMID: 38886297 Free PMC article. Review.
-
Benefits of Liver Volume and Serum Zinc Level Assessment for the Screening of Covert Hepatic Encephalopathy in Patients with Child-Pugh Class A Cirrhosis.Diagnostics (Basel). 2024 Dec 25;15(1):23. doi: 10.3390/diagnostics15010023. Diagnostics (Basel). 2024. PMID: 39795551 Free PMC article.
-
CT-scan Based Liver and Spleen Volume Measurement as a Prognostic Indicator for Patients with Cirrhosis.Am J Med Sci. 2021 Sep;362(3):252-259. doi: 10.1016/j.amjms.2020.10.031. Epub 2020 Nov 2. Am J Med Sci. 2021. PMID: 33947583 Free PMC article.
-
Impact of genetic variants linked to liver fat and liver volume on MRI-mapped body composition.JHEP Rep. 2025 Jun 2;7(9):101468. doi: 10.1016/j.jhepr.2025.101468. eCollection 2025 Sep. JHEP Rep. 2025. PMID: 40823175 Free PMC article.
-
Liver volume based prediction model for patients with hepatitis B virus-related acute-on-chronic liver failure.J Hepatobiliary Pancreat Sci. 2022 Dec;29(12):1253-1263. doi: 10.1002/jhbp.1112. Epub 2022 Jan 25. J Hepatobiliary Pancreat Sci. 2022. PMID: 35029044 Free PMC article.
References
-
- Gines P, et al., Compensated cirrhosis: natural history and prognostic factors. Hepatology, 1987. 7(1): p. 122–128. - PubMed
-
- D’Amico G, Garcia-Tsao G, and Pagliaro L, Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol, 2006. 44(1): p. 217–31. - PubMed
-
- Garcia-Tsao G, Current Management of the Complications of Cirrhosis and Portal Hypertension: Variceal Hemorrhage, Ascites, and Spontaneous Bacterial Peritonitis. Dig Dis, 2016. 34(4): p. 382–6. - PubMed
-
- Garcia-Tsao G, et al., Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases. Hepatology, 2017. 65(1): p. 310–335. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical